Researcher
Kurt Vermeire
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Jul 2002 → Today - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Jun 2002
Projects
1 - 10 of 23
- The role of the trigger factor chaperone in protein sorting and secretory targeting, Acronym: TFaSTFrom1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of protein translocation inhibitors of the ER Sec61 protein-conducting channelFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Structural dynamics of secretory protein sorting, targeting, translocation (DynamicSTarT)From1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Study of cellular factors involved in Respiratory Syncytial Virus (RSV) infectionFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The construction of biologically contained filovirus systems and their purposes in antiviral compound screening and receptor binding associated studies.From18 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Non-folding signals and their decoding by chaperones in the secretory pathwayFrom27 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Cryo-EM study of a CADA-stalled human CD4 protein nascent chain in the Sec61 ER transloconFrom1 Jul 2021 → 31 Dec 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Study of the prophylactic effect of the corticosteroid Fluticasone Propionate (FP) on SARS-CoV-2 infectionFrom1 Jan 2021 → 31 Dec 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization of a fusion assay to study virus entry inhibitors of SARS-CoV-2From1 Jul 2020 → 30 Jun 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Novel piperidineisothiazopyridines with antiviral activity against Respiratory Syncytieel Virus (RSV)From1 Jan 2020 → 31 Dec 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 69
- Entry inhibitors for human respiratory virus SARS-CoV-2.(2023)
Authors: Emiel Vanhulle, Kurt Vermeire, Piet Maes, Lieve Naesens, Dominique Schols
- Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients(2023)
Authors: Jan Van Slambrouck, Erik Verbeken, Vincent Geudens, Simon Feys, Emiel Vanhulle, Kurt Vermeire, Lucia Aversa, Janne Kaes, Dirk Van Raemdonck, Robin Vos, et al.
Pages: 1 - 20 - Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface(2023)
Authors: Emiel Vanhulle, Sam Noppen, Lieve Naesens, Annelies Stevaert, Kurt Vermeire
- Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants(2023)
Authors: Emiel Vanhulle, Jordi Doijen, Sam Noppen, Dominique Schols, Annelies Stevaert, Kurt Vermeire
- A Multimodal Imaging-Supported Down Syndrome Mouse Model of RSV Infection(2023)
Authors: Birger Tielemans, Lander De Herdt, Emilie Pollenus, Emiel Vanhulle, Laura Seldeslachts, Nora Marain, Flore Belmans, Kaveh Ahookhosh, Jeroen Vanoirbeek, Kurt Vermeire, et al.
- MOLECULAR EVOLUTION OF A NEW EBOLA VIRUS STRAIN AND ANALYSIS OF KIR GENE VARIANTS IN EBOLA VIRUS DISEASE(2023)
Authors: Tony Wawina, Piet Maes, Kurt Vermeire
- Structural insights into TRAP association with ribosome-Sec61 complex and translocon inhibition by a CADA derivative.(2023)
Authors: Eva Pauwels, Neesha Rajesh Shewakramani, Piet Maes, Kurt Vermeire, Kalyan Das
- Design and synthesis of a new series of hybrids of functionalised N 1-[(1H-1,2,3-triazol- 4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial Virus(2023)
Authors: Robert Snoeck, Emiel Vanhulle, Mirthe Graus, Graciela Andrei, Dominique Schols, Kurt Vermeire
- Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro(2023)
Authors: Katleen Martens, Emiel Vanhulle, An-sofie Viskens, Brecht Steelant, Peter Hellings, Kurt Vermeire
- De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells(2022)
Authors: Sara Akalay, Kurt Vermeire, Ben Sprangers, Elena Levtchenko
Pages: 2791 - 2803